Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas Thornton

Showing results (11-20 of 81) with videos related to

Pageof 9
Sort By:
Pharmacoepidemiology and Drug Safety|January 18, 2021
Factors associated with the use of the prescription monitoring program by prescribers and pharmacists in TexasJames Douglas Thornton, Tyler J Varisco, Callie G Downs
Journal of Addiction Medicine|February 20, 2025
Association Between Buprenorphine Adherence Trajectories, Health Outcomes, and Health Care Costs Among Medicaid EnrolleesOlajumoke A Olateju, Chijioke Okeke, Mina Shrestha, et al.
BMJ Open|December 3, 2017
Cardiovascular mortality and oral antidiabetic drugs: protocol for a systematic review and network meta-analysisRashmi Goyat, James Douglas Thornton, Xi Tan, et al.
Journal of the American Pharmacists Association : Japha|April 23, 2023
The impact of the mainstreaming addiction treatment act and associated legislative action on pharmacy practiceTyler J Varisco, Matthew Wanat, Lucas G Hill, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 4, 2017
Health-related quality of life in patients receiving long-term opioid therapy: a systematic review with meta-analysisJ Douglas Thornton, Rashmi Goyat, Nilanjana Dwibedi, et al.
The Annals of Pharmacotherapy|October 9, 2025
Duration of Concurrent Oxycodone and Selective Serotonin Reuptake Inhibitors Use and the Risk of Opioid OverdoseChijioke Okeke, Olajumoke Olateju, Ismaeel Yunusa, et al.
Journal of the American Pharmacists Association : Japha|February 7, 2017
Pharmacists' readiness to provide naloxone in community pharmacies in West VirginiaJ Douglas Thornton, Elizabeth Lyvers, Virginia Ginger G Scott, et al.
Frontiers in Pain Research (Lausanne, Switzerland)|January 28, 2026
Pain severity and opioid use in patients with spine-related diagnosesChijioke M Okeke, Javeria Khalid, J Douglas Thornton, et al.
Journal of Managed Care & Specialty Pharmacy|November 29, 2024
Marginal health care expenditures for melanoma care in the United StatesOlajumoke A Olateju, Jieni Li, J Douglas Thornton, et al.
Journal of the American Pharmacists Association : Japha|February 19, 2020
Prescription drug disposal: Products available for home useFiona Imarhia, Tyler J Varisco, Matthew A Wanat, et al.
Pageof 9

Showing results (11-20 of 81) with videos related to

Sort By:
Pageof 9
Pharmacoepidemiology and Drug Safety|January 18, 2021
Factors associated with the use of the prescription monitoring program by prescribers and pharmacists in TexasJames Douglas Thornton, Tyler J Varisco, Callie G Downs
Journal of Addiction Medicine|February 20, 2025
Association Between Buprenorphine Adherence Trajectories, Health Outcomes, and Health Care Costs Among Medicaid EnrolleesOlajumoke A Olateju, Chijioke Okeke, Mina Shrestha, et al.
BMJ Open|December 3, 2017
Cardiovascular mortality and oral antidiabetic drugs: protocol for a systematic review and network meta-analysisRashmi Goyat, James Douglas Thornton, Xi Tan, et al.
Journal of the American Pharmacists Association : Japha|April 23, 2023
The impact of the mainstreaming addiction treatment act and associated legislative action on pharmacy practiceTyler J Varisco, Matthew Wanat, Lucas G Hill, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 4, 2017
Health-related quality of life in patients receiving long-term opioid therapy: a systematic review with meta-analysisJ Douglas Thornton, Rashmi Goyat, Nilanjana Dwibedi, et al.
The Annals of Pharmacotherapy|October 9, 2025
Duration of Concurrent Oxycodone and Selective Serotonin Reuptake Inhibitors Use and the Risk of Opioid OverdoseChijioke Okeke, Olajumoke Olateju, Ismaeel Yunusa, et al.
Journal of the American Pharmacists Association : Japha|February 7, 2017
Pharmacists' readiness to provide naloxone in community pharmacies in West VirginiaJ Douglas Thornton, Elizabeth Lyvers, Virginia Ginger G Scott, et al.
Frontiers in Pain Research (Lausanne, Switzerland)|January 28, 2026
Pain severity and opioid use in patients with spine-related diagnosesChijioke M Okeke, Javeria Khalid, J Douglas Thornton, et al.
Journal of Managed Care & Specialty Pharmacy|November 29, 2024
Marginal health care expenditures for melanoma care in the United StatesOlajumoke A Olateju, Jieni Li, J Douglas Thornton, et al.
Journal of the American Pharmacists Association : Japha|February 19, 2020
Prescription drug disposal: Products available for home useFiona Imarhia, Tyler J Varisco, Matthew A Wanat, et al.
Pageof 9